HomeProductsBioactive CompoundsMAPK/ERK PathwayERKRavoxertinib
Chemical structure of CAS 1453848-26-4

Ravoxertinib

CAS No.1453848-26-4
MDL No.MFCD28143918
MFC21H18ClFN6O2
MW440.90
InChI KeyRZUOCXOYPYGSKL-GOSISDBHSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1453848-26-4
Product NameRavoxertinib

Biological Targets

MAPK3·MAPK1

Associated Conditions

neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.

Toxicology in vitro : an international journal published in association with BIBRA • Vol. 65 • 2020
PMID: 31962201DOI: 10.1016/j.tiv.2020.104777

Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development.

Journal of medicinal chemistry • Vol. 59, Issue 12 • 2016
PMID: 27227380DOI: 10.1021/acs.jmedchem.6b00389

[Determination of GSH-DH activity (E.C.1.8.5.1) presence of the enzyme in different wheat varieties (author's transl)].

Zeitschrift fur Lebensmittel-Untersuchung und -Forschung • Vol. 158, Issue 2 • 1975
PMID: 1914DOI: 10.1007/BF01460024

Documentation